These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 2658204)

  • 1. Detection of Vibrio vulnificus cytolysin in V. vulnificus-infected mice.
    Gray LD; Kreger AS
    Toxicon; 1989; 27(4):439-64. PubMed ID: 2658204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of anti-Vibrio vulnificus cytolysin antibodies in sera from mice and a human surviving V. vulnificus disease.
    Gray LD; Kreger AS
    Infect Immun; 1986 Mar; 51(3):964-5. PubMed ID: 3949387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mouse skin damage caused by cytolysin from Vibrio vulnificus and by V. vulnificus infection.
    Gray LD; Kreger AS
    J Infect Dis; 1987 Feb; 155(2):236-41. PubMed ID: 3805762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Vibrio vulnificus by indirect immunofluorescence.
    Gray LD; Kreger AS
    Diagn Microbiol Infect Dis; 1985 Nov; 3(6):461-8. PubMed ID: 3905226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vibrio vulnificus cytolysin induces inflammatory responses in RAW264.7 macrophages through calcium signaling and causes inflammation in vivo.
    Qin K; Fu K; Liu J; Wu C; Wang Y; Zhou L
    Microb Pathog; 2019 Dec; 137():103789. PubMed ID: 31605759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary damage by Vibrio vulnificus cytolysin.
    Park JW; Ma SN; Song ES; Song CH; Chae MR; Park BH; Rho RW; Park SD; Kim HR
    Infect Immun; 1996 Jul; 64(7):2873-6. PubMed ID: 8698528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The extracellular cytolysin of Vibrio vulnificus: inactivation and relationship to virulence in mice.
    Wright AC; Morris JG
    Infect Immun; 1991 Jan; 59(1):192-7. PubMed ID: 1846124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of Novel Inflammatory Cytokines and Contribution of Keratinocyte-Derived Chemokine to Inflammation in Response to Vibrio vulnificus Infection in Mice.
    Liu XF; Wu J; Wang MY; Chen YJ; Cao Y; Hu CJ
    Inflammation; 2015 Oct; 38(5):1864-73. PubMed ID: 25862020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Vibrio vulnificus O serovars with antilipopolysaccharide monoclonal antibody.
    Martin SJ; Siebeling RJ
    J Clin Microbiol; 1991 Aug; 29(8):1684-8. PubMed ID: 1761690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vibrio vulnificus VvhA induces Th1 and Tfh cells to proliferate against Vibrio vulnificus in a mouse model of infection.
    Wang MY; Liu XF; Xia J; Li Y; Geng JL; Hu CJ
    Future Microbiol; 2017 Sep; 12():953-965. PubMed ID: 28816516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytotoxic mechanism of Vibrio vulnificus cytolysin in CPAE cells.
    Rho HW; Choi MJ; Lee JN; Park JW; Kim JS; Park BH; Sohn HS; Kim HR
    Life Sci; 2002 Mar; 70(16):1923-34. PubMed ID: 12005177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Preparation of monoclonal antibodies against flagellin core protein of Vibrio vulnificus and its application in testing Vibrio vulnificus from food products].
    Zeng J; Cheng J; Zhang L; Zhang L; Zhang H; Wei H; Liu X; Cao D
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Oct; 29(10):1068-71. PubMed ID: 24103267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RTX toxin enhances the survival of Vibrio vulnificus during infection by protecting the organism from phagocytosis.
    Lo HR; Lin JH; Chen YH; Chen CL; Shao CP; Lai YC; Hor LI
    J Infect Dis; 2011 Jun; 203(12):1866-74. PubMed ID: 21422475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vibrio vulnificus MARTX cytotoxin causes inactivation of phagocytosis-related signaling molecules in macrophages.
    Chen CL; Chien SC; Leu TH; Harn HI; Tang MJ; Hor LI
    J Biomed Sci; 2017 Aug; 24(1):58. PubMed ID: 28822352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Preparation and characterization of monoclonal antibody against Vibrio vulnificus].
    Fu KF; Ma C; Guo JW; Qiao YY; Hao XH; Wang DP
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Mar; 28(3):279-81. PubMed ID: 22394637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and vaccine efficacy of an attenuated Vibrio vulnificus strain with deletions in major cytotoxin genes.
    Kim YR; Lee SE; Kim JR; Rhee JH
    FEMS Microbiol Lett; 2015 Dec; 362(23):fnv169. PubMed ID: 26381905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vibrio vulnificus infection: clinical manifestations, pathogenesis, and antimicrobial therapy.
    Chiang SR; Chuang YC
    J Microbiol Immunol Infect; 2003 Jun; 36(2):81-8. PubMed ID: 12886957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purification and characterization of Vibrio metschnikovii cytolysin.
    Miyake M; Honda T; Miwatani T
    Infect Immun; 1988 Apr; 56(4):954-60. PubMed ID: 3126150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Virulence of Vibrio vulnificus strains from marine environments.
    Tison DL; Kelly MT
    Appl Environ Microbiol; 1986 May; 51(5):1004-6. PubMed ID: 3729387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vibrio vulnificus cytolysin induces hyperadhesiveness of pulmonary endothelial cells for neutrophils through endothelial P-selectin: a mechanism for pulmonary damage by Vibrio vulnificus cytolysin.
    Kim BS; Kim JS
    Exp Mol Med; 2002 Sep; 34(4):308-12. PubMed ID: 12515397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.